Interleukin-10 improves stroke outcome by controlling the detrimental Interleukin-17A responseMarius Piepke, Mathias Gelderblom, Björn Rissiek et al.|Journal of Neuroinflammation|2021Cited by 66
A preclinical randomized controlled multi-centre trial of anti-interleukin-17A treatment for acute ischaemic strokeMathias Gelderblom, Tim Magnus, Jan‐Kolja Strecker et al.|Brain Communications|2023Cited by 12
Interleukin-10 Improves Stroke Outcome by Controlling the Detrimental Interleukin-17A ResponseMarius Piepke, Mathias Gelderblom, Bettina Hjelm Clausen et al.|Research Square|2021Cited by 0